Elevance Health stock (US2855211023): health insurer in focus after latest quarterly earnings

Elevance Health has reported fresh quarterly figures and updated its outlook, keeping the US health insurance giant on investors’ radar. What drives the business model and revenues behind the stock?

Elevance Health recently published its latest quarterly results, giving investors fresh insight into the performance of one of the largest US health insurers. The company reported higher revenue and earnings for the first quarter of 2026 compared with the prior-year period, supported by growth in its commercial and government health plans, according to Elevance Health investor relations as of 04/24/2026. The group also reaffirmed its full-year 2026 outlook, as reported by Reuters as of 04/24/2026.

As of: 15.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Elevance Health
• Sector/industry: Health insurance, managed care, health services
• Headquarters/country: Indianapolis, United States
• Core markets: US commercial and government-sponsored health plans
• Key revenue drivers: Premiums from medical insurance plans, pharmacy and care management services
• Home exchange/listing venue: New York Stock Exchange (ticker: ELV)
• Trading currency: US dollar (USD)

Elevance Health: core business model

Elevance Health is one of the largest health benefits companies in the United States, offering a broad range of medical, pharmacy, behavioral health and related services. The group traces its roots to regional Blue Cross and Blue Shield plans and today operates health plans under several brands, focusing on commercial employers, individual consumers and government programs. Its model is centered on collecting premiums and managing medical costs while providing access to networks of doctors, hospitals and pharmacies, according to Elevance Health company information as of 2025.

The company’s main business is organized around its health benefits segment, which includes health plans for large national accounts, local employer groups and individuals. Elevance Health also participates in US government-sponsored programs such as Medicaid and Medicare Advantage, serving beneficiaries through managed care arrangements. Beyond traditional insurance, the firm increasingly positions itself as a health solutions provider, offering analytics, care management and pharmacy services aimed at improving outcomes and lowering costs, as highlighted in its strategic overview in Elevance Health strategy materials as of 2025.

Risk management is central to the business model. Elevance Health sets premiums based on actuarial projections of medical claims, administrative expenses and regulatory requirements. The company aims to maintain a competitive medical loss ratio, which measures claims costs relative to premiums, while meeting minimum coverage standards under US healthcare regulation. The ability to accurately price risk and negotiate favorable contracts with providers and pharmaceutical companies strongly influences profitability, according to commentary in the firm’s annual report published in early 2025 for the 2024 financial year, as noted by Elevance Health annual report 2024 as of 02/21/2025.

Main revenue and product drivers for Elevance Health

Premium revenue from health plans remains the primary source of income for Elevance Health. The company earns premiums from employers that sponsor health coverage for their workforce, from individuals buying coverage directly and from government agencies paying for Medicaid and Medicare managed care services. In the full year 2024, the company reported tens of millions of medical members and generated the bulk of its revenue from health premiums, according to its annual report for 2024 published on 02/21/2025, as cited by Elevance Health annual report 2024 as of 02/21/2025.

The product mix spans commercial group plans, individual and family plans, Medicare Advantage, Medicare Part D, Medicaid managed care and specialty products such as dental and vision coverage. Elevance Health also earns fees from administrative services-only (ASO) contracts, where it manages health benefits for self-funded employer plans without taking on full insurance risk. These fee-based arrangements generate revenue from services rather than premiums and generally carry lower risk but also lower margins compared with fully insured products, according to Reuters as of 02/21/2025.

Another important revenue driver is the pharmacy benefit management and services business. Through its care and pharmacy services segment, Elevance Health provides medication management, specialty pharmacy services and related solutions to health plans and employers. This segment aims to control drug spending and improve patient adherence by negotiating discounts and managing formularies. Growth in complex specialty medications and chronic disease management has increased the strategic relevance of these services, as highlighted in the company’s 2024 Form 10-K filed with the US Securities and Exchange Commission and referenced by SEC filing as of 02/21/2025.

For Elevance Health, membership growth and retention in key segments are critical indicators. In recent reporting periods, the company has pointed to stable or growing enrollment in Medicare and Medicaid plans, offset by competitive dynamics in certain commercial markets. In the first quarter of 2026, management commented that solid performance in fee-based and government businesses supported overall revenue and earnings trends, according to Bloomberg as of 04/24/2026.

Why Elevance Health matters for US investors

Elevance Health plays a prominent role in the US healthcare system as a major managed care company. For investors in the United States, the stock provides exposure to trends in employer-sponsored health coverage, Medicare Advantage expansion and Medicaid enrollment dynamics. As healthcare spending continues to represent a significant share of US gross domestic product, large insurers are positioned at the center of funding and managing care. Elevance Health’s scale and influence in negotiations with providers and pharmaceutical firms can shape pricing trends across the market, according to Bloomberg sector report as of 11/15/2025.

The stock may also react sensitively to regulatory developments in Washington, D.C. Debates around Medicare Advantage payment rates, Medicaid redeterminations and potential changes to the Affordable Care Act can all influence Elevance Health’s enrollment and profitability. Additionally, broader US economic conditions, including employment levels and wage growth, affect employer-based coverage demand. Investors following the stock often watch macroeconomic data and policy announcements alongside company-specific earnings and guidance, as noted by Reuters as of 10/03/2025.

Conclusion

Elevance Health’s recent quarterly figures and confirmed outlook keep the health insurer in the spotlight for market participants who follow the US managed care sector. The group’s business model relies on managing medical cost trends while expanding membership in attractive segments such as Medicare Advantage and Medicaid. At the same time, the company remains exposed to regulatory decisions and shifts in US healthcare policy, as well as competition from other large insurers and new care models. For investors, ongoing monitoring of earnings reports, membership metrics and policy developments may be important when assessing how the stock fits into a diversified portfolio.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.